Modification of P3-cap. From tert-butylurea (compound 1) to

P3-P4 ureas and reverse carbamates as potent HCV NS3 protease

Pharmaceuticals, Free Full-Text

Challenges in Modern Drug Discovery: A Case Study of Boceprevir

Pharmaceuticals, Free Full-Text

Pharmaceuticals, Free Full-Text

Arun K. Ghosh and Sandra Gemma Structure-based Design of Drugs and

Arun K. Ghosh and Sandra Gemma Structure-based Design of Drugs and

Arun K. Ghosh and Sandra Gemma Structure-based Design of Drugs and

The Journey to the Discovery of Boceprevir: An NS3–NS4 HCV

Discovery of the HCV NS3/4A Protease Inhibitor (1R,5S)-N-[3-Amino

Efficient and Selective Palladium‐Catalysed C‐3 Urea Couplings to

Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor

Hepatitis C: The Story of a Long Journey through First, Second

Modification of P3-cap. From tert-butylurea (compound 1) to

Hepatitis C: The Story of a Long Journey through First, Second